Insilico Medicine's Major Listing Boosts AI Innovation in Drug Discovery
Discover how Insilico Medicine's IPO on the Hong Kong Exchange is revolutionizing drug discovery with AI, drawing significant investor interest and market confidence.
FDA Approves First Blood Test to Aid Alzheimer’s Diagnosis
The FDA has approved Lumipulse, the first blood test for Alzheimer's diagnosis in symptomatic older adults, enabling less invasive detection of amyloid plaques and supporting earlier, accurate diagnosis and treatment options.